Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Biogen Pharmachem
Join Channel
Consolidated Standalone

Biogen Pharmachem

₹1.1 0 | 0%

Market Cap ₹73 Cr.

Stock P/E 73.7

P/B 1.3

Current Price ₹1.1

Book Value ₹ 0.9

Face Value 1

52W High ₹1.9

Dividend Yield 0%

52W Low ₹ 0.6

Edit Ratio

Biogen Pharmachem Research see more...

Overview Inc. Year: 1995Industry: Trading

Biogen Pharmachem Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Biogen Pharmachem Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 1 0 -0 -2 0 0 -0 1 0 0
Other Income -0 0 0 0 2 0 0 0 1 0
Total Income 1 0 -0 -2 2 0 -0 1 1 0
Total Expenditure 1 0 0 0 0 0 0 0 0 0
Operating Profit 0 0 -0 -2 2 0 -0 0 1 0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 0 -0 -2 2 0 -0 0 1 0
Provision for Tax 0 0 0 0 0 0 0 0 0 0
Profit After Tax 0 0 -0 -2 2 0 -0 0 1 0
Adjustments 0 0 0 0 0 0 0 0 -0 0
Profit After Adjustments 0 0 -0 -2 2 0 -0 0 1 0
Adjusted Earnings Per Share 0 0 -0 -0 0 0 -0 0 0 0

Biogen Pharmachem Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 0 0 0 0 0 0 1 0 2 2 0 1
Other Income 0 0 0 0 0 0 0 0 0 0 1 1
Total Income 0 0 0 0 0 0 1 0 2 2 1 2
Total Expenditure 0 0 0 0 0 7 1 0 3 2 0 0
Operating Profit -0 -0 -0 -0 -0 -7 -0 -0 -2 -0 0 1
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -0 -0 -0 -0 -0 -7 -0 -0 -2 -0 0 1
Provision for Tax 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Tax -0 -0 -0 -0 -0 -7 -0 -0 -2 -0 0 1
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -0 -0 -0 -0 -0 -7 -0 -0 -2 -0 0 1
Adjusted Earnings Per Share -0 -0 -0 -0 -0 -0.1 -0 -0 -0 -0 0 0

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -100% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 67% 72% 43% 14%
ROE Average 1% -1% -0% -1%
ROCE Average 1% -1% -0% -1%

Biogen Pharmachem Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 61 61 61 61 61 54 54 56 54 54 55
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 8 6 1 0 1 0 0 0 0
Other Non-Current Liabilities 2 2 2 2 2 2 2 0 0 0 0
Total Current Liabilities 2 61 3 0 0 0 1 0 0 1 0
Total Liabilities 65 123 73 69 63 56 58 56 54 55 55
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 19 76 45 55 63 49 50 48 52 53 55
Total Current Assets 46 47 29 14 0 7 8 8 3 2 0
Total Assets 65 123 73 69 63 56 58 56 54 55 55

Biogen Pharmachem Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 1 0 0 0 0 0 0 0 0
Cash Flow from Operating Activities 22 0 -7 5 -0 -14 0 -1 4 1 2
Cash Flow from Investing Activities -46 -9 17 17 4 14 -1 2 -4 -1 -2
Cash Flow from Financing Activities 24 10 -11 -22 -4 -1 1 -0 -0 0 0
Net Cash Inflow / Outflow -0 1 -1 0 -0 -0 -0 0 0 0 0
Closing Cash & Cash Equivalent 0 1 0 0 0 0 0 0 0 0 0

Biogen Pharmachem Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) -0 -0 -0 -0 -0 -0.1 -0 -0 -0.02 -0 0.01
CEPS(Rs) -0 -0 -0 -0 -0 -0.1 -0 -0 -0.02 -0 0.01
DPS(Rs) 0 0 0 0 0 0 0 0 0 0 0
Book NAV/Share(Rs) 0.94 0.94 0.93 0.93 0.93 0.83 0.83 0.85 0.83 0.83 0.84
Core EBITDA Margin(%) 0 0 0 0 0 0 -0.37 0 -98.8 -0.61 0
EBIT Margin(%) 0 0 0 0 0 0 -0.37 0 -98.8 -0.34 0
Pre Tax Margin(%) 0 0 0 0 0 0 -0.37 0 -98.81 -0.35 0
PAT Margin (%) 0 0 0 0 0 0 -0.37 0 -98.81 -0.35 0
Cash Profit Margin (%) 0 0 0 0 0 0 -0.37 0 -98.81 -0.35 0
ROA(%) -0.2 -0.14 -0.13 -0.04 -0.18 -11.01 -0.01 -0.21 -2.91 -0.02 0.83
ROE(%) -0.22 -0.21 -0.22 -0.05 -0.2 -11.4 -0.01 -0.21 -2.92 -0.02 0.84
ROCE(%) -0.21 -0.14 -0.14 -0.04 -0.19 -11.33 -0.01 -0.21 -2.91 -0.02 0.84
Receivable days 0 0 0 0 0 0 2893.16 0 1188.42 0 0
Inventory Days 0 0 0 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 218.81 0 15 0 0
PER(x) 0 0 0 0 0 0 0 0 0 0 84.29
Price/Book(x) 0.22 0.32 0.22 0.24 0.23 0 0.28 0.22 0.25 1.69 0.71
Dividend Yield(%) 0 0 0 0 0 0 0 0 0 0 0
EV/Net Sales(x) 0 0 0 0 0 0 16.46 0 8.44 36.89 0
EV/Core EBITDA(x) -102.35 -582.04 -178.46 -740.87 -119.12 -9.94 -4467.7 -108.85 -8.54 0 84.23
Net Sales Growth(%) -100 0 0 0 0 0 0 -100 0 52.48 -100
EBIT Growth(%) -40.57 2.83 -2.05 79.14 -337.23 -5340.04 99.95 -3234.19 -1273.79 99.48 5523.81
PAT Growth(%) -40.95 2.81 -2.03 78.78 -328.78 -5331.37 99.95 -3189.27 -1273.83 99.46 5396.51
EPS Growth(%) -44.25 4.76 0 80 -375 -5194.74 99.9 -1700 -1266.67 99.59 7100
Debt/Equity(x) 0 0.94 0.16 0.1 0.01 0 0.01 0.01 0 0 0
Current Ratio(x) 20.13 0.78 8.83 287.14 0.61 145.53 7.06 198.39 23.64 2.37 0.65
Quick Ratio(x) 934.95 0.78 8.83 287.14 0.61 145.53 7.06 198.39 23.64 2.37 0.65
Interest Cover(x) -253.04 -240.94 -253.51 -46.87 -622.73 0 -73.22 0 0 -42 4556
Total Debt/Mcap(x) 0 2.92 0.73 0.43 0.05 0 0.04 0.02 0 0 0

Biogen Pharmachem Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 0 0 0 0 0 0 0 0 0 0
FII 0 0 0 0 0 0 0 0 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 100 100 100 100 100 100 100 100 100 100
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 0%.
  • Company has a low return on equity of -1% over the last 3 years.
  • Earnings include an other income of Rs. 1 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Biogen Pharmachem News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!